Takeaways -
Greater China companies operating in any industry can now obtain secondary listings in Hong Kong, provided they meet market capitalization minimums.
Recent Listing Rules amendments also allow some companies...more
HKEx Finalizes New Rules on Listings for Overseas Issuers -
Following a consultation process conducted earlier in 2021, the Stock Exchange of Hong Kong Limited (HKEx) has announced amended listing rules for overseas...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
10/8/2021
/ Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Private Investment in Public Equity (PIPEs) ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
With ongoing regulatory developments affecting capital markets globally, many China-related businesses are considering pursuing their IPOs in Hong Kong. However, the regulatory regime for IPOs on the Stock Exchange of Hong...more
查看中文 - This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEX), and their advisers. In particular,...more
4/15/2021
/ Annual Reports ,
Corporate Governance ,
Disclosure Requirements ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Listing Rules ,
New Guidance ,
Publicly-Traded Companies ,
Takeover Code
On February 23, 2018, the Stock Exchange of Hong Kong Limited (HKEX) published its consultation conclusions regarding a new chapter of its listing rules to facilitate the listings of pre-revenue biotech companies in Hong...more
Despite the impact of COVID-19 and other recent developments in Hong Kong, the city’s role as a center for China-based companies to raise capital became even more important in 2020. The momentum of several trends that began...more
1/29/2021
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Foreign Relations ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
PCAOB ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC)
查看中文 -
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
The Hong Kong Stock Exchange continues to pursue and implement a number of rule changes aimed at making the listing process more efficient while strengthening and broadening its role overseeing listed companies and the tools...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
7/14/2020
/ Acquisitions ,
Amended Rules ,
Biotechnology ,
Board of Directors ,
Censures ,
Corporate Executives ,
Enforcement Actions ,
False Statements ,
Hang Seng China Enterprises Index (HSCEI) ,
Hang Seng Index (HSI) ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Internal Controls ,
Listing Applications ,
Listing Rules ,
Medical Devices ,
Medical Research ,
Mergers ,
Misappropriation ,
Misleading Statements ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Sanctions ,
Secondary Listings ,
SFC ,
Shareholders ,
Takeovers ,
Weighted Voting Rights (WVR)
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their advisers. In particular,...more
4/3/2020
/ Annual Reports ,
Coronavirus/COVID-19 ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Listing Rules ,
Publicly-Traded Companies ,
Regulatory Requirements ,
relief ,
Relief Measures ,
Shareholder Meetings ,
Virtual Meetings ,
Weighted Voting Rights (WVR)
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
1/8/2020
/ Acquisitions ,
Annual Reports ,
Beneficial Owner ,
Board of Directors ,
Breach of Duty ,
Censures ,
Compensation ,
Complex Corporate Transactions ,
Conflicts of Interest ,
Controlling Person ,
Criminal Convictions ,
Cross-Border Transactions ,
Debt Securities ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Failure to Cooperate ,
Filing Deadlines ,
Foreign Acquisitions ,
Foreign Offerings ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Securities Clearing Company Limited (HKSCC) ,
Hong Kong Stock Exchange ,
Insider Trading ,
Investment Adviser ,
Listing Rules ,
Mandatory Disclosure Rules ,
Materiality ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Reporting Requirements ,
Secondary Listings ,
Shareholder Approval ,
Trial Court Orders
This update provides an overview of recent developments that will affect preparation of annual results and annual reports for companies listed on The Stock Exchange of Hong Kong Limited (HKEX).
In particular, it covers...more
1/6/2020
/ Annual Reports ,
Biotechnology ,
Capital Requirements ,
Committee Meetings ,
Corporate Governance ,
Disclosure Requirements ,
Dual Class Share Structures ,
EBITDA ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Financial Statements ,
Foreign Corporations ,
Foreign Issuers ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Investment Funds ,
Listing Rules ,
Materiality ,
Non-GAAP Financial Measures ,
Publicly-Traded Companies ,
Secondary Listings ,
Shareholder Meetings ,
Trade Suspensions ,
Voting Rights
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
10/8/2019
/ Acquisitions ,
Censures ,
Consultation Periods ,
Corporate Issuers ,
Disclosure Requirements ,
Enforcement Actions ,
Fines ,
Foreign Issuers ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Public Consultations ,
Security Token Offering (STOs) ,
Stock Connect ,
Takeovers
This edition provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
7/5/2019
/ Accounting Standards ,
Acquisitions ,
Audit Policies ,
Board of Directors ,
CEOs ,
China ,
Conflicts of Interest ,
Controlling Stockholders ,
Criminal Prosecution ,
Disclosure Requirements ,
Disqualification ,
Due Diligence ,
Economic Sanctions ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Financial Reporting ,
Fines ,
Foreign Investment ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Insider Information ,
Listing Rules ,
Mergers ,
Non-GAAP Financial Measures ,
Office of Foreign Assets Control (OFAC) ,
Publicly-Traded Companies ,
Risk Assessment ,
The Market Misconduct Tribunal (MMT) ,
Trade Suspensions ,
Variable Interest Entities
In the past year, nearly a dozen companies have taken advantage of new rules to list on the Stock Exchange of Hong Kong Limited (HKEx). On April 30, 2018, HKEx introduced a series of reforms to encourage the listing of...more
6/19/2019
/ Biotechnology ,
China ,
Corporate Executives ,
Dual Class Share Structures ,
EU ,
Food and Drug Administration (FDA) ,
HKEx ,
Hong Kong Stock Exchange ,
Innovative Technology ,
Listing Rules ,
Patent Registration ,
Popular ,
Publicly-Traded Companies ,
Research and Development ,
Shareholders ,
Threshold Requirements ,
United States ,
Weighted Voting Rights (WVR)
This Hong Kong regulatory update provides an overview of key regulatory developments in the past three months relevant to companies listed (or planning to list) on The Stock Exchange of Hong Kong Limited (HKEx) and their...more
4/5/2019
/ Accounting Standards ,
Annual Reports ,
Best Practices ,
Censures ,
Corporate Governance ,
Disclosure Requirements ,
Due Diligence ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Failure to Comply ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Leases ,
Listing Rules ,
Material Misrepresentation ,
New Guidance ,
Omissions ,
Publicly-Traded Companies ,
Regulatory Standards ,
Securities ,
Shareholder Approval ,
Stock Connect ,
Weighted Voting Rights (WVR)